Innovation Pharmaceuticals Inc. (IPIX)

Market Cap	370.14K +600.0%
Revenue (ttm)	n/a
Net Income	-2.62M
EPS	-0.01
Shares Out	528.77M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,500
Average Volume	147,580
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0007
52-Week Range	n/a
Beta	158.38
RSI	44.97
Earnings Date	n/a

About IPIX

Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellc...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: IPIX